QICE Capital Partners

Our LPs & Co-Investment Partners are mostly Asia's & Global top family offices, listed corps decision-makers, founders with successful exits and UHNWIs, which gives QCP unique advantages to empower companies we partner-up. For direct investment opportunities, we can only invest after 3-6 months working with the selected companies through our investment banking/advisory activities.

QCP is committed to bridging the business gaps across Asia and Global disruptive AI/deeptech companies, foward-looking healthcare & wellness companies & creative consumer brands by introducing sales & expansion channels to global companies as well as helping next generation of Chinese companies expanding overseas. 

QCP generally works with & invests in mid-to-late stage tech, consumer and healthcare companies by maximizing their strategic premium by empowering them with business development, next-round private-equity/debt fundraising, liquidity planning and exit optimization. 

QCP currently focuses on direct investment opportunities only at growth/late stage companies in Asia (40%) & US/Europe/Israel(60%). We as well remain a curious alternative fund manager exploring proprietary opportunities in hedge fund & alternative assets with high emphasis on steadily alpha return to ourself & our LPs.

QCP has built vast Asian & Global founders, elite business leaders & investors network (30,000+ investors) for co-investment opportunities. We're in the process of mapping out a competitive new model for private equity investment aiming to fully utilize AGI reforming the alternative investment worlds.

Our entire model centers around adding significant value to our post-investment portfolio companies. We will continuously leverage deep & curated relationships with top industry leaders in tech, consumer & healthcare areas to offer hands-on advice to our long-term partner companies.